Collective comparison at Bayer

$BAYN (-7,71%)

On February 17, 2026, Bayer reached an extensive class settlement in the United States to resolve ongoing litigation over the weedkiller glyphosate (Roundup™). The Group is increasing its provisions for legal risks to a total of 11.8 billion euros . The settlement is intended to pave the way out of the legal uncertainty.

The decision is aimed at securing long-term legal peace in the U.S. following large damage judgments against the company Beck.de.

Class settlement: Monsanto (Bayer subsidiary) to pay Bayer a maximum of USD 7.25 billion over up to 21 years.
Provisions: Total provisions for litigation increase from €7.8 billion to €11.8 billion, of which €9.6 billion relates to glyphosate Bayer, 4investors.com.
Additional funds: Further confidential settlements have been agreed to settle ongoing cases Bayer.
Financing: US$8 billion credit facility secures immediate action from Bayer.

Chiefwiggum@Hidalidsch

I really wouldn't have thought of the comeback

•

Patrick Schäfer@Hotte1909

@Hidalidsch no way would I have expected that. I would have rather expected a takeover by kws or fmc at the low point, at least of the agricultural division. And then the medical division by one of the big players. But as the saying goes, if you don't have the shares at the bottom, you don't have them at the top.

Steppenwolf66@Steppenwolf66

I had some a few months ago and got out with a good profit. Let's see what happens with Monsanto, they also produce the controversial herbicide Roundup...